General information
  • Disease category Respiratory diseases (non cancer) (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    Zurich
    (BASEC)
  • Contact Silvia Ulrich pulmonalehypertonie@usz.ch (BASEC)
  • Data Source(s) BASEC: Import from 05.06.2026 ICTRP: N/A
  • Last update 05.06.2026 10:20
HumRes68287 | SNCTP000006940 | BASEC2026-00059

Walking Test without Oxygen Therapy versus with Oxygen Therapy

  • Disease category Respiratory diseases (non cancer) (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    Zurich
    (BASEC)
  • Contact Silvia Ulrich pulmonalehypertonie@usz.ch (BASEC)
  • Data Source(s) BASEC: Import from 05.06.2026 ICTRP: N/A
  • Last update 05.06.2026 10:20

Summary description of the study

In the case of a lung disease, the 6-minute walking test is performed as a standard examination. This assesses physical performance. You are already familiar with this test from the usual visits to us in the pulmonology department at USZ. In this study, we investigate whether patients with lung diseases can walk as far with additional oxygen during the walking test (intervention 'Walking Test with Oxygen', ≥4 liters/minute) as they can without oxygen administration.

(BASEC)

Intervention under investigation

Walking test with and without nasal low-flow oxygen therapy.

(BASEC)

Disease under investigation

Lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, or interstitial pneumonia

(BASEC)

Criteria for participation in trial
- Minimum age 18 years - Written informed consent - Patients with diagnosed pulmonary arterial hypertension (PAH), distal chronic thromboembolic pulmonary hypertension (CTEPH), chronic obstructive pulmonary disease (COPD) with emphysema, COPD without emphysema, or interstitial lung disease - Previous desaturation under exertion, defined as SpO2 decrease >3% - Treatment with stable medication therapy (without changes for at least 14 days prior to screening) (BASEC)

Exclusion criteria
- Severe hypoxemia requiring additional oxygen therapy, defined as PaO2 < 6.9 kPa - Inability or contraindications to perform the investigated intervention - Inability to follow the study procedures, e.g., due to language problems, mental disorders, dementia, walking disabilities, etc. (BASEC)

Trial sites

Zurich

(BASEC)

not available

Sponsor

Universitätsspital Zürich, Klinik für Pneumologie

(BASEC)

Contact

Contact Person Switzerland

Silvia Ulrich

0432534336

pulmonalehypertonie@usz.ch

Universitätsspital Zürich, Klinik für Pneumologie

(BASEC)

Scientific Information

not available

Name of the authorising ethics committee (for multicentre studies, only the lead committee)

Ethics Committee Zurich

(BASEC)

Date of authorisation

05.06.2026

(BASEC)


ICTRP Trial ID
not available

Official title (approved by ethics committee)
Exercise performance on ambient air vs. commonly prescribed nasal low flow oxygen therapy in patients with exercise induced desaturation due to pulmonary disease (BASEC)

Academic title
not available

Public title
not available

Disease under investigation
not available

Intervention under investigation
not available

Type of trial
not available

Trial design
not available

Inclusion/Exclusion criteria
not available

not available

Primary and secondary end points
not available

not available

Registration date
not available

Incorporation of the first participant
not available

Secondary sponsors
not available

Additional contacts
not available

Secondary trial IDs
not available

Results-Individual Participant Data (IPD)
not available

Further information on the trial
not available

Results of the trial

Results summary

not available

Link to the results in the primary register

not available